Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Palacios

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Immunology and Allergy Clinics of North America|September 30, 2019
Asthma Self-management: It's Not One Size Fits AllLisa Ulrich, Sabrina Palacios
Journal of Medical Education and Curricular Development|January 1, 2024
Novel and Engaging Teaching Method for Pulmonary PhysiologyLisa M Ulrich, Sabrina Palacios, Debra Boyer, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 7, 2020
Impact of asthma severity on long-term asthma controlShahid I Sheikh, Nancy A Ryan-Wenger, Judy Pitts, et al.
Chest|August 29, 2025
Intermittent Asthma and Risk of Severe Exacerbation in ChildrenShahid Sheikh, Mariah Eisner, Wheaton Kelin, et al.
Pediatric Pulmonology|July 1, 2022
Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infectionSabrina Palacios, Katelyn Krivchenia, Mariah Eisner, et al.
Pulmonary Pharmacology & Therapeutics|February 20, 2025
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosisShahid Sheikh, Melissa Holtzlander, Mariah Eisner, et al.
Respiratory Medicine|July 30, 2025
Real -world impact of previous exposure to CFTR modulators on clinical parameters and chronic sinus disease in people with cystic fibrosis on elexacaftor-tezacaftor-ivacaftorMelissa Holtzlander, Meredith Lind, Mariah Eisner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 3, 2019
Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosisBenjamin T Kopp, James Fitch, Lisa Jaramillo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Immunology and Allergy Clinics of North America|September 30, 2019
Asthma Self-management: It's Not One Size Fits AllLisa Ulrich, Sabrina Palacios
Journal of Medical Education and Curricular Development|January 1, 2024
Novel and Engaging Teaching Method for Pulmonary PhysiologyLisa M Ulrich, Sabrina Palacios, Debra Boyer, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 7, 2020
Impact of asthma severity on long-term asthma controlShahid I Sheikh, Nancy A Ryan-Wenger, Judy Pitts, et al.
Chest|August 29, 2025
Intermittent Asthma and Risk of Severe Exacerbation in ChildrenShahid Sheikh, Mariah Eisner, Wheaton Kelin, et al.
Pediatric Pulmonology|July 1, 2022
Long-term pulmonary sequelae in adolescents post-SARS-CoV-2 infectionSabrina Palacios, Katelyn Krivchenia, Mariah Eisner, et al.
Pulmonary Pharmacology & Therapeutics|February 20, 2025
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosisShahid Sheikh, Melissa Holtzlander, Mariah Eisner, et al.
Respiratory Medicine|July 30, 2025
Real -world impact of previous exposure to CFTR modulators on clinical parameters and chronic sinus disease in people with cystic fibrosis on elexacaftor-tezacaftor-ivacaftorMelissa Holtzlander, Meredith Lind, Mariah Eisner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 3, 2019
Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosisBenjamin T Kopp, James Fitch, Lisa Jaramillo, et al.
Pageof 1